[vc_row content_placement=”top” css=”.vc_custom_1513372836541{margin-top: 0px !important;padding-top: 0px !important;}”][vc_column width=”1/2″][vc_column_text]

AIVLOSIN® 17%

(Tylvalosin Medicated Premix)
Veterinary use only

[/vc_column_text][vc_row_inner css=”.vc_custom_1516639645105{margin-bottom: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”619″ img_size=”full” css=”.vc_custom_1521038185271{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][/vc_column_inner][/vc_row_inner][vc_row_inner css=”.vc_custom_1513716818578{margin-bottom: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1/2″][vc_btn title=”Product Profile” style=”custom” custom_background=”#327ba3″ custom_text=”#ffffff” align=”center” i_icon_fontawesome=”fa fa-download” add_icon=”true” link=”url:https%3A%2F%2Fpharmgate.com%2Fcanada%2Fwp-content%2Fuploads%2F2018%2F08%2FAIVLOSIN-17_Canada-Product-Profile-Sheet-1089.0518-8.27.18.pdf||target:%20_blank|”][/vc_column_inner][vc_column_inner width=”1/2″][vc_btn title=”Safety Data Sheet” style=”custom” custom_background=”#327ba3″ custom_text=”#ffffff” align=”center” i_icon_fontawesome=”fa fa-download” add_icon=”true” link=”url:https%3A%2F%2Fpharmgate.com%2Fcanada%2Fwp-content%2Fuploads%2F2021%2F07%2FAIVLOSIN%C2%AE-17-Tylvalosin-Type-A-Medicated-Article-Premix-US-EN-6-sds.pdf||target:%20_blank|”][/vc_column_inner][/vc_row_inner][vc_tta_accordion active_section=”0″ collapsible_all=”true” css=”.vc_custom_1513632528790{margin-top: 0px !important;padding-top: 0px !important;}”][vc_tta_section title=”Product Description” tab_id=”1513201865211-a42523b6-7183″][vc_column_text]

  • Aivlosin® 17% contains 170 g/kg tylvalosin (supplied as tylvalosin tartrate) for oral use in medicating complete feed for swine
  • For the treatment of Porcine Proliferative Enteropathy (PPE) associated with Lawsonia intracellularis in pigs
  • Tylvalosin, the active ingredient in Aivlosin 17%, is a macrolide antibiotic
  • Free-flowing granules
  • Veterinary use only
  • 10 kg bags

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Key Features” tab_id=”1513792168267-b1150847-969c”][vc_column_text]

  • For the treatment of Porcine Proliferative Enteropathy (PPE)/ileitis associated with Lawsonia intracellularis infection in pigs
  • Broad spectrum, potent macrolide not used in human health
  • Accumulates rapidly in target tissues with intracellular concentrations many times extracellular levels
  • Reliable dosing, consistent mixing
  • Requires a prescription from a veterinarian
  • No withdrawal period is required when treated according to the label
  • Wide safety margin

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Label Indications and Dosage” tab_id=”1513716844386-780f8db5-df08″][ultimate_exp_section title=”Swine” text_color=”#0a0a0a” background_color=”rgba(255,255,255,0.01)” bghovercolor=”rgba(0,0,0,0.01)” title_active_bg=”rgba(244,244,244,0.01)” cnt_bg_color=”rgba(255,255,255,0.01)” icon=”Defaults-plus” new_icon=”Defaults-minus” icon_align=”left” icon_size=”15″ title_alignment=”left” title_margin=”margin:0px;” title_padding=”padding:0px;”][vc_column_text css=”.vc_custom_1526481189096{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]For Swine: Treatment of Porcine Proliferative Enteropathy (PPE) associated with Lawsonia intracellularis infection in pigs.

WARNINGS:
No withdrawal period is required when treated according to the label. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals; therefore, people with known hypersensitivity to tylvalosin tartrate should avoid contact with this product.
When mixing and handling Aivlosin® 17%, avoid inhalation, oral exposure and direct contact with skin or eyes. Keep out of reach of children.

DESCRIPTION:
Aivlosin® 17% contains 170 g/kg tylvalosin (supplied as tylvalosin tartrate) for oral use in medicating complete feed for swine.

THERAPEUTIC CLASSIFICATION:
Tylvalosin, the active ingredient in Aivlosin 17%, is a macrolide antibiotic.

INDICATIONS:
For the treatment of Porcine Proliferative Enteropathy (PPE) associated with Lawsonia intracellularis in pigs.

TARGET SPECIES: Pigs.

DOSAGE AND ADMINISTRATION:
To reduce the development of antimicrobial resistance and maintain effectiveness, use this antibiotic prudently.
For Feed Manufacturing Use Only.
Do not feed undiluted.
Aivlosin® 17% must be thoroughly mixed into feeds before use.
Thoroughly mix 0.25 kg Aivlosin® 17% with 999.75 kg of complete feed to obtain a medicated feed with tylvalosin concentration of 0.00425% (42.5 g/1000 kg).
To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin® 17% into a small portion of the feed (at least 10 kg per tonne of finished feed) and mix. Blend this mixture into the remainder of the feed and mix thoroughly. Feed as the sole ration for 14 consecutive days.

CAUTIONS: Not for use in breeding animals.
The effects of tylvalosin on male and female reproductive performance, including pregnancy and lactation, have not been determined.
Do not use in feeds containing pellet binding agents with the exception of Lignosol (4%) and Agri-Colloid (0.3%).
Do not use in feeds containing bentonite.
Acute cases and severely diseased pigs with reduced food and water intake should be treated with a suitable injectable product. It is sound clinical practice to base treatment on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of target bacteria. Use of the product deviating from the instructions may increase the risk of development and selection of resistant bacteria and decrease the effectiveness of treatment with other macrolides due to the potential for cross-resistance.

ADVERSE REACTIONS:
No adverse reactions related to the drug were observed during clinical or target animal safety trials.

The Safety Data Sheet contains more detailed occupational safety information.

[/vc_column_text][/ultimate_exp_section][/vc_tta_section][vc_tta_section title=”Withdrawal Period” tab_id=”1513264661363-6748f0e1-b32e”][vc_column_text]

  • No withdrawal period is required when treated according to the label

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Packaging” tab_id=”1513264908146-ea47139b-48ba”][vc_column_text]

  • 10 kg (22.07 lbs)

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Formulation” tab_id=”1513201865229-293b2c0c-7650″][vc_column_text]

  • Free-flowing granules.
  • Formulated for optimal dispersion, segregation, and stability in feed.

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Storage” tab_id=”1521569716369-f8ae897a-c384″][vc_column_text]

  • Store in a cool dry place at or below 25ºC.

[/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][vc_column width=”1/2″][vc_single_image image=”1419″ img_size=”full” alignment=”center”][vc_row_inner css=”.vc_custom_1513632376535{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1/3″][/vc_column_inner][vc_column_inner width=”1/3″][vc_column_text]


Available in Canada

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.

[/vc_column_text][/vc_column][/vc_row]